Reuters logo
BRIEF-Vertex Pharmaceuticals says FTC requested for additional information on pending acquisition from Concert Pharmaceuticals
May 22, 2017 / 12:10 PM / 7 months ago

BRIEF-Vertex Pharmaceuticals says FTC requested for additional information on pending acquisition from Concert Pharmaceuticals

May 22 (Reuters) - Concert Pharmaceuticals Inc

* Vertex Pharmaceuticals says on May 19, the U.S. FTC issued a request for additional information in connection co’s pending acquisition of CTP-656 and other assets from Concert Pharmaceuticals

* The second request was issued under notification requirements of the Hart-Scott-Rodino antitrust improvements act

* Vertex Pharmaceuticals says it intends to work cooperatively with the FTC as it reviews the transaction Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below